Published in Women's Health Weekly, March 24th, 2005
"The Solis platform will be positioned to complement our existing aesthetic product lines and will address a significant need in the market," said Eric Reuter, Laserscope president and CEO.
"The addressable market includes not only new practitioners who are considering offering cosmetic treatments to their patients, but also the thousands of physicians who have purchased devices in the past that are no...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.